584
Views
33
CrossRef citations to date
0
Altmetric
CASE REPORT

Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder

, , , &
Pages 743-746 | Received 21 Feb 2015, Accepted 20 Apr 2015, Published online: 08 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Zhaolin Li, Qiaojun Zeng, Shuwan Xu, Yuewei Li, Tiantian Tang, Jianting Shi, Xueming Song, Wenman He, Liang Chen, Guirong Liu, Boying Gao, Jianming Zheng, Linjie Huang, Ming Chen & Shanping Jiang. (2023) Development and Validation of a Nomogram for Predicting Tigecycline-Related Coagulopathy: A Retrospective Cohort Study. Infection and Drug Resistance 16, pages 423-434.
Read now
Haibo Lei, Xiang Liu, Zuojun Li & Chunjiang Wang. (2023) Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia. Journal of Chemotherapy 35:4, pages 292-297.
Read now
Yu Huang, Libin Chen, Handuo Su, Zhenwei Huang, Xiaoyi Li & Shubao Huang. (2022) Tigecycline treatment causes a decrease in peripheral blood platelet. Journal of Chemotherapy 0:0, pages 1-5.
Read now
Gianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou & Vittorio Magri. (2022) Safety considerations with new antibacterial approaches for chronic bacterial prostatitis. Expert Opinion on Drug Safety 21:2, pages 171-182.
Read now
Jia Liu, Yingying Yan & Fan Zhang. (2021) Risk Factors for Tigecycline-Associated Hypofibrinogenemia. Therapeutics and Clinical Risk Management 17, pages 325-332.
Read now
Damla Akdağ, Meltem Işıkgöz-Taşbakan, Hüsnü Pullukcu, Hilal Sipahi & Oğuz Reşat Sipahi. (2020) Tigecycline versus INR increase; more than expected?. Expert Opinion on Drug Safety 19:3, pages 335-337.
Read now

Articles from other publishers (25)

Xiaoxuan Yang, Lu Jin, Xuemei Luo, Shurun An, Min Wang, Huaijun Zhu, Yujie Zhou & Hang Liu. (2023) Pharmacokinetic/Pharmacodynamic Target Attainment of Tigecycline in Patients with Hepatic Impairment in a Real-World Setting. Therapeutic Drug Monitoring Publish Ahead of Print.
Crossref
Chuwen Lin, Miaoqin Tan, Dongmei Wang, Chunping Gu, Yongming Wu & Shengnan Wang. (2023) Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study. Pharmacology 108:6, pages 540-549.
Crossref
Mingxing Guo, Jinwei Liang, Dandan Li, Ying Zhao, Wanyi Xu, Lei Wang & Xiangli Cui. (2022) Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database. Thrombosis Journal 20:1.
Crossref
Tingting Jiang, Xuhui Huang, Qinghua Liu, Hangwei Feng, Yiting Huang, Jian Lin, Long Huang, Shufang Chen, Yingfeng Zhuang & Cuilian Weng. (2022) Risk Factors for Tigecycline‐Associated Hepatotoxicity in Patients in the Intensive Care Units of 2 Tertiary Hospitals: A Retrospective Study. The Journal of Clinical Pharmacology 62:11, pages 1426-1434.
Crossref
Bing Leng, Chengwu Shen, Tiantian Gao, Kai Zhao, Xuemei Zhao, Yujin Guo, Jiyong Wu, Jing Yang, Wei Fang, Jicheng Zhang, Yahui Zhang, Chao Sun, Lei Duan, Jing Huang, Yougang Qi & Genquan Yan. (2022) Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China. Frontiers in Pharmacology 13.
Crossref
Sajad Yaghoubi, Angelina Olegovna Zekiy, Marcela Krutova, Mehrdad Gholami, Ebrahim Kouhsari, Mohammad Sholeh, Zahra Ghafouri & Farajolah Maleki. (2021) Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. European Journal of Clinical Microbiology & Infectious Diseases 41:7, pages 1003-1022.
Crossref
Dongmei Wang, Chuwen Lin, Chunping Gu, Yongming Wu & Shengnan Wang. (2022) Tigecycline-Associated Coagulopathy: A Single-Center Retrospective Analysis. Pharmacology 107:9-10, pages 524-536.
Crossref
Müge AYHAN, Ferda CAN, Selma KARAAHMETOĞLU & Rahmet GÜNER. (2021) Hypofibrinogenemia caused by tigecycline use in a patient with acute cholecystitis: a case report and review of the literature. The European Research Journal 7:6, pages 667-671.
Crossref
Xiaoping Shi, Chengchun Zuo, Lingling Yu, Donghui Lao, Xiaoyu Li, Qing Xu & Qianzhou Lv. (2021) Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM. Frontiers in Pharmacology 12.
Crossref
Benedikt Treml, Sasa Rajsic, Tobias Hell, Dietmar Fries & Mirjam Bachler. (2021) Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis. Journal of Clinical Medicine 10:20, pages 4702.
Crossref
Qian Zhang, Jine Wang, Hui Liu, Wang Ma, Suming Zhou & Jing Zhou. (2020) Risk factors for tigecycline‐induced hypofibrinogenaemia. Journal of Clinical Pharmacy and Therapeutics 45:6, pages 1434-1441.
Crossref
David Campany-Herrero, Maria Larrosa-Garcia, Pilar Lalueza-Broto, Lucas Rivera-Sánchez, Juan Espinosa-Pereiro, Jaume Mestre-Torres & Carles Pigrau-Serrallach. (2020) Tigecycline-associated hypofibrinogenemia in a real-world setting. International Journal of Clinical Pharmacy 42:4, pages 1184-1189.
Crossref
Juan Hu, Yong-hong Xiao, Yi Zheng, Yang-xiao Lai, Xue-ling Fang & Qiang Fang. (2020) Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients. European Journal of Clinical Pharmacology 76:7, pages 913-922.
Crossref
Hakeam A. Hakeam & Zainab Al Duhailib. (2020) Tigecycline-induced coagulopathy: a literature review. International Journal of Clinical Pharmacy 42:3, pages 846-847.
Crossref
Anna Brandtner, Mirjam Bachler, Dietmar Fries, Martin Hermann, Jacqueline Ruehlicke, Vilmos Fux, Andrea Griesmacher, Christian Niederwanger, Tobias Hell & Benedikt Treml. (2020) Tigecycline Interferes with Fibrinogen Polymerization Independent of Peripheral Interactions with the Coagulation System. Antibiotics 9:2, pages 84.
Crossref
Qiaomei Fan, Wei Huang, Yayun Weng, Xianze Xie & Zheng Shi. (2020) Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature. Medicine 99:43, pages e22638.
Crossref
Jian Liu, Yiqing Liu, Shengjun Liu, Qin Zhang, Jiexin Zheng, Yiwen Niu & Xuefeng Wang. (2019) Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients. Burns & Trauma 7.
Crossref
Nannan Cui, Hongliu Cai, Zhitao Li, Yuting Lu, Guobin Wang & Anwei Lu. (2019) Tigecycline-induced coagulopathy: a literature review. International Journal of Clinical Pharmacy 41:6, pages 1408-1413.
Crossref
Bing Leng, Yuan Chao Xue, Wen Zhang, Tian tian Gao, Gen quan Yan & Hui Tang. (2019) A Retrospective Analysis of the Effect of Tigecycline on Coagulation Function. Chemical and Pharmaceutical Bulletin 67:3, pages 258-264.
Crossref
Jinhong Gong, Dan Su, Jingjing Shang, Hai Yu, Guantao Du, Ying Lin, Zhiqiang Sun & Guangjun Liu. (2019) Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases. Medicine 98:38, pages e17091.
Crossref
Pei-Chun Wu & Chien-Chih Wu. (2018) Tigecycline-associated hypofibrinogenemia: A case report and review of the literature. IDCases 11, pages 56-57.
Crossref
Xiaoqin Wu, Ping Zhao, Liang Dong & Xiuhong Zhang. (2017) A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia. Medicine 96:49, pages e9124.
Crossref
Hanae Makita, Keiki Nagaharu, Manami Teramoto, Yuji Bessho, Takanori Yamaguchi, Ryugo Ito & Keiki Kawakami. (2017) Severe Coagulopathy Associated with Tigecycline for the <i>Achromobacter Xylosoxydans</i> Bacteremia in a Patient with Follicular Lymphoma濾胞性リンパ腫治療中に発症した<i>Achromobacter xylosoxidans</i>菌血症に対しtigecyclineを使用し凝固障害を来たした1例. Nihon Naika Gakkai Zasshi 106:8, pages 1626-1631.
Crossref
. (2016) Tigecycline. Reactions Weekly 1599:1, pages 212-212.
Crossref
Yeong Jin JeongByeongzu GhanhJi Wan LeeJinoh ParkTae-Bum KimYou Sook ChoHee-Bom MoonHyouk-Soo Kwon. (2016) Rapid-onset of severe tigecycline-induced coagulopathy in drug reaction with eosinophilia and systemic symptom syndrome. Allergy, Asthma & Respiratory Disease 4:1, pages 74.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.